Locations
Redwood City, CA, USA · South San Francisco, CA, USA
industry
Biotechnology
Size
11 - 50 employees
Stage
Other
founded in
2022
NewLimit is a biotechnology company that focuses on extending human healthspan through epigenetic reprogramming of cells. The company develops innovative medicines aimed at restoring youthful function in aging cells, targeting age-related diseases. NewLimit employs cutting-edge research to explore the potential of cellular rejuvenation, contributing to advancements in biomedicine. By utilizing epigenetic techniques, the company seeks to provide solutions that enhance the quality of life as individuals age. Its approach represents a significant shift in how age-related conditions are understood and treated, paving the way for new therapeutic options.
Something looks off?On-site & Remote